Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Revium Rx (RVRC) EBIT (2025 - 2026)

Updated

Revium Rx's EBIT was -$732,000 in Q2 2026.

Analysis

Revium Rx (RVRC) EBIT (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 6.18 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 6.43 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 3.16 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.39 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 4.27 Bn
10 Revium Rx 86.84 Mn 86.00 Mn - -732,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -732,000.00
Jun 30, 2025 -938,000.00
API Access

Revium Rx EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=RVRC&period=max&api_key=YOUR_API_KEY